텔레뉴로로지 시장 규모, 점유율, 동향 분석 : 서비스별, 최종 용도별, 용도별, 지역별 전망과 예측(2025-2032년)

The Global Teleneurology Market size is expected to reach $13.51 billion by 2032, rising at a market growth of 11.2% CAGR during the forecast period.

Key Highlights:

• The North America market dominated the Global Market in 2024, accounting for a 34.80% revenue share in 2024.
• The US Teleneurology market is expected to continue its dominance in North America region thereby reaching a market size of 1.61 billion by 2032.
• Among the various services segments, Tele-Consulting dominated the global market, contributing a revenue share of 45.11% in 2024.
• In terms of the Application segmentation, the Stroke segment is projected to dominate the global market with the projected revenue share of 23.76%m in 2032.
• Providers servers led the End Use segments in 2024, capturing a 51.17% revenue share and is projected to continue its dominance during projected period.

The teleneurology market has transformed from its beginning in late-20th-century initial virtual care trials to an important part of neurological care. Firstly, it was focused on swift stroke consultations, now it has extended to manage conditions such as Parkinson's disease, epilepsy, multiple sclerosis, and migraine. Governmental health plans, regulatory support, and the COVID-19 pandemic-induced adoption have sped up its incorporation into routine care. Advancements in internet technology, wearable neuro-monitoring devices, AI-powered diagnostics, and cloud-based EMR access have enabled teleneurology to expand specialist care to rural and underserved communities globally, helping to bridge the neurologist shortage and meet the growing burden of neurological diseases.

Key trends are the use of AI for real-time diagnosis and predictive monitoring, the growth of neurology-specific mHealth apps for tracking symptoms, and cross-border teleconsultations made possible by national telemedicine portals. Global healthcare companies, nimble startups, and government programs all affect competition in the market. Philips Healthcare, GE HealthCare, and Medtronic are adding teleneurology to bigger digital health platforms-hospitals like the Mayo Clinic work with tech companies to expand their services. Strategic partnerships, specialized training programs, and new ideas that focus on a specific area, like pediatric neurology or neurorehabilitation, are all helping to set the sector apart. This makes it very competitive and full of chances for growth.

COVID 19 Impact Analysis

The COVID-19 pandemic accelerated the adoption of teleneurology by shifting neurological care from in-person consultations to virtual platforms, addressing challenges posed by restricted hospital visits and strained resources. It enabled continued management of conditions like stroke, epilepsy, and Parkinson's disease through video consultations, remote monitoring, and AI-assisted diagnostics, particularly benefiting rural and underserved areas. Emergency departments leveraged virtual stroke assessments to improve treatment efficiency while reducing infection risks. Collaborative efforts among healthcare providers, technology firms, and regulators, supported by temporary policy relaxations and expanded reimbursements, fueled rapid integration. However, infrastructure limitations and digital literacy gaps hindered uniform adoption, especially in developing regions. Overall, the pandemic established a strong foundation for teleneurology's long-term growth and integration into healthcare systems.

Services Outlook

Based on service, the global teleneurology market is segmented into teleconsulting, tele-monitoring, and tele-education. The teleconsulting segment garnered the 45.1% revenue share in the market in 2024. It allows patients to consult neurologists remotely through video conferencing or digital platforms, reducing the need for physical travel and enabling faster diagnosis and treatment planning. This service is particularly effective in rural and underserved areas, where access to specialized neurological care is limited. Hospitals, clinics, and standalone neurologists are increasingly integrating tele-consultation platforms into their systems to streamline workflows, improve patient engagement, and extend their service reach.

Application Outlook

By application, the global teleneurology market is divided into Stroke, Parkinson, Epilipesy, Headache, Multiple sclerosis, Dementia, and Other Application. The stroke segment witnessed the 27.2% revenue share in the market in 2024. Teleneurology enables timely intervention through remote consultations, especially in rural or underserved areas lacking access to neurologists. Hospitals are increasingly utilizing telestroke programs to facilitate quicker decision-making and improve outcomes for patients experiencing acute strokes.

Regional Outlook

Based on the Region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. North America leads with a 34.80% share in 2024. North America is the leader in the global teleneurology market because of its advanced healthcare systems, strong broadband connections, and policies that help pay for teleneurology services in the U.S. and Canada. High rates of neurological diseases, early use of AI-based diagnostics, and big programs like the National Teleneurology Program from the U.S. Department of Veterans Affairs have all helped the market grow. Major hospital networks like the Mayo Clinic and Cleveland Clinic, as well as tech-healthcare partnerships, are still making it easier for specialists to see patients, especially in rural areas.

Europe, Asia Pacific, and LAMEA have significant growth potential. Germany, the U.K., and France are the most advanced countries in adopting cross-border teleconsultation, which is good for Europe's strong public healthcare and regulatory support. The Asia Pacific region is growing the fastest because more people are getting access to the internet, the government in China and India is supporting telemedicine, and more money is being put into neuro-monitoring tools. Adoption of LAMEA is starting to happen, with Brazil, the UAE, and South Africa moving forward with pilot projects and mobile health solutions. Even though there are still gaps in infrastructure, more connectivity and global partnerships are expected to speed up adoption.

List of Key Companies Profiled

• Teladoc Health, Inc.
• American Well Corporation (Amwell)
• MDLive, Inc.
• Blue Sky Telehealth (CarePoint, P.C.)
• Siemens Healthineers AG (Siemens AG)
• Access TeleCare Holdings, Inc.
• Sevaro Health, Inc.
• GlobalMed Holdings, LLC (GlobalMed)
• Lakewood Health System
• TeleSpecialists

Global Teleneurology Market Report Segmentation

By Service

• Tele-Consulting
• Tele-Monitoring
• Tele-Education

By End Use

• Providers
• Patients
• Payers

By Application

• Stroke
• Parkinson
• Epilipesy
• Headache
• Multiple sclerosis
• Dementia
• Other Application

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Teleneurology Market, by Service
  • 1.4.2 Global Teleneurology Market, by End Use
  • 1.4.3 Global Teleneurology Market, by Application
  • 1.4.4 Global Teleneurology Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Market Trends - Teleneurology Market

Chapter 5. State of Competition - Teleneurology Market

Chapter 6. PLC (Product Life Cycle) - Teleneurology Market

Chapter 7. Market Consolidation Teleneurology Market

Chapter 8. Value Chain Analysis of Teleneurology Market

• 8.1 Technology Infrastructure Development
• 8.2 Medical Device and Equipment Supply
• 8.3 Clinical Service Delivery
• 8.4 Integration with Healthcare Facilities
• 8.5 Reimbursement and Regulatory Compliance
• 8.6 Patient Engagement and Outcome Monitoring
• 8.7 Data Analytics and Reporting
• 8.8 Marketing, Outreach, and Provider Network Expansion
• 8.9 Training and Support Services
• 8.10. Feedback Loop and Continuous Innovation

Chapter 9. Key Customer Criteria - Teleneurology Market

Chapter 10. Global Teleneurology Market by Service

• 10.1 Global Tele-Consulting Market by Region
• 10.2 Global Tele-Monitoring Market by Region
• 10.3 Global Tele-Education Market by Region

Chapter 11. Global Teleneurology Market by End Use

• 11.1 Global Providers Market by Region
• 11.2 Global Patients Market by Region
• 11.3 Global Payers Market by Region

Chapter 12. Global Teleneurology Market by Application

• 12.1 Global Stroke Market by Region
• 12.2 Global Parkinson Market by Region
• 12.3 Global Epilipesy Market by Region
• 12.4 Global Headache Market by Region
• 12.5 Global Multiple sclerosis Market by Region
• 12.6 Global Dementia Market by Region
• 12.7 Global Other Application Market by Region

Chapter 13. Global Teleneurology Market by Region

• 13.1 North America Teleneurology Market
• 13.2 Key Factors Impacting the Market
  • 13.2.1 Market Drivers
  • 13.2.2 Market Restraints
  • 13.2.3 Market Opportunities
  • 13.2.4 Market Challenges
  • 13.2.5 Market Trends Teleneurology Market
  • 13.2.6 Market State of Competition Teleneurology Market
  • 13.2.7 North America Teleneurology Market by Service
    • 13.2.7.1 North America Tele-Consulting Market by Country
    • 13.2.7.2 North America Tele-Monitoring Market by Country
    • 13.2.7.3 North America Tele-Education Market by Country
  • 13.2.8 North America Teleneurology Market by End Use
    • 13.2.8.1 North America Providers Market by Country
    • 13.2.8.2 North America Patients Market by Country
    • 13.2.8.3 North America Payers Market by Country
  • 13.2.9 North America Teleneurology Market by Application
    • 13.2.9.1 North America Stroke Market by Country
    • 13.2.9.2 North America Parkinson Market by Country
    • 13.2.9.3 North America Epilipesy Market by Country
    • 13.2.9.4 North America Headache Market by Country
    • 13.2.9.5 North America Multiple sclerosis Market by Country
    • 13.2.9.6 North America Dementia Market by Country
    • 13.2.9.7 North America Other Application Market by Country
  • 13.2.10 North America Teleneurology Market by Country
    • 13.2.10.1 US Teleneurology Market
      • 13.2.10.1.1 US Teleneurology Market by Service
      • 13.2.10.1.2 US Teleneurology Market by End Use
      • 13.2.10.1.3 US Teleneurology Market by Application
    • 13.2.10.2 Canada Teleneurology Market
      • 13.2.10.2.1 Canada Teleneurology Market by Service
      • 13.2.10.2.2 Canada Teleneurology Market by End Use
      • 13.2.10.2.3 Canada Teleneurology Market by Application
    • 13.2.10.3 Mexico Teleneurology Market
      • 13.2.10.3.1 Mexico Teleneurology Market by Service
      • 13.2.10.3.2 Mexico Teleneurology Market by End Use
      • 13.2.10.3.3 Mexico Teleneurology Market by Application
    • 13.2.10.4 Rest of North America Teleneurology Market
      • 13.2.10.4.1 Rest of North America Teleneurology Market by Service
      • 13.2.10.4.2 Rest of North America Teleneurology Market by End Use
      • 13.2.10.4.3 Rest of North America Teleneurology Market by Application
• 13.3 Europe Teleneurology Market
• 13.4 Key Factors Impacting the Market
  • 13.4.1 Market Drivers
  • 13.4.2 Market Restraints
  • 13.4.3 Market Opportunities
  • 13.4.4 Market Challenges
  • 13.4.5 Market Trends of Teleneurology Market
  • 13.4.6 State of Competition Teleneurology Market
  • 13.4.7 Europe Teleneurology Market by Service
    • 13.4.7.1 Europe Tele-Consulting Market by Country
    • 13.4.7.2 Europe Tele-Monitoring Market by Country
    • 13.4.7.3 Europe Tele-Education Market by Country
  • 13.4.8 Europe Teleneurology Market by End Use
    • 13.4.8.1 Europe Providers Market by Country
    • 13.4.8.2 Europe Patients Market by Country
    • 13.4.8.3 Europe Payers Market by Country
  • 13.4.9 Europe Teleneurology Market by Application
    • 13.4.9.1 Europe Stroke Market by Country
    • 13.4.9.2 Europe Parkinson Market by Country
    • 13.4.9.3 Europe Epilipesy Market by Country
    • 13.4.9.4 Europe Headache Market by Country
    • 13.4.9.5 Europe Multiple sclerosis Market by Country
    • 13.4.9.6 Europe Dementia Market by Country
    • 13.4.9.7 Europe Other Application Market by Country
  • 13.4.10 Europe Teleneurology Market by Country
    • 13.4.10.1 Germany Teleneurology Market
      • 13.4.10.1.1 Germany Teleneurology Market by Service
      • 13.4.10.1.2 Germany Teleneurology Market by End Use
      • 13.4.10.1.3 Germany Teleneurology Market by Application
    • 13.4.10.2 UK Teleneurology Market
      • 13.4.10.2.1 UK Teleneurology Market by Service
      • 13.4.10.2.2 UK Teleneurology Market by End Use
      • 13.4.10.2.3 UK Teleneurology Market by Application
    • 13.4.10.3 France Teleneurology Market
      • 13.4.10.3.1 France Teleneurology Market by Service
      • 13.4.10.3.2 France Teleneurology Market by End Use
      • 13.4.10.3.3 France Teleneurology Market by Application
    • 13.4.10.4 Russia Teleneurology Market
      • 13.4.10.4.1 Russia Teleneurology Market by Service
      • 13.4.10.4.2 Russia Teleneurology Market by End Use
      • 13.4.10.4.3 Russia Teleneurology Market by Application
    • 13.4.10.5 Spain Teleneurology Market
      • 13.4.10.5.1 Spain Teleneurology Market by Service
      • 13.4.10.5.2 Spain Teleneurology Market by End Use
      • 13.4.10.5.3 Spain Teleneurology Market by Application
    • 13.4.10.6 Italy Teleneurology Market
      • 13.4.10.6.1 Italy Teleneurology Market by Service
      • 13.4.10.6.2 Italy Teleneurology Market by End Use
      • 13.4.10.6.3 Italy Teleneurology Market by Application
    • 13.4.10.7 Rest of Europe Teleneurology Market
      • 13.4.10.7.1 Rest of Europe Teleneurology Market by Service
      • 13.4.10.7.2 Rest of Europe Teleneurology Market by End Use
      • 13.4.10.7.3 Rest of Europe Teleneurology Market by Application
• 13.5 Asia Pacific Teleneurology Market
• 13.6 Key Factors Impacting the Market
  • 13.6.1 Market Drivers
  • 13.6.2 Market Restraints
  • 13.6.3 Market Opportunities
  • 13.6.4 Market Challenges
  • 13.6.5 Market Trends Asia Pacific Teleneurology Market
  • 13.6.6 State of Competition Asia Pacific Teleneurology Market
  • 13.6.7 Asia Pacific Teleneurology Market by Service
    • 13.6.7.1 Asia Pacific Tele-Consulting Market by Country
    • 13.6.7.2 Asia Pacific Tele-Monitoring Market by Country
    • 13.6.7.3 Asia Pacific Tele-Education Market by Country
  • 13.6.8 Asia Pacific Teleneurology Market by End Use
    • 13.6.8.1 Asia Pacific Providers Market by Country
    • 13.6.8.2 Asia Pacific Patients Market by Country
    • 13.6.8.3 Asia Pacific Payers Market by Country
  • 13.6.9 Asia Pacific Teleneurology Market by Application
    • 13.6.9.1 Asia Pacific Stroke Market by Country
    • 13.6.9.2 Asia Pacific Parkinson Market by Country
    • 13.6.9.3 Asia Pacific Epilipesy Market by Country
    • 13.6.9.4 Asia Pacific Headache Market by Country
    • 13.6.9.5 Asia Pacific Multiple sclerosis Market by Country
    • 13.6.9.6 Asia Pacific Dementia Market by Country
    • 13.6.9.7 Asia Pacific Other Application Market by Country
  • 13.6.10 Asia Pacific Teleneurology Market by Country
    • 13.6.10.1 China Teleneurology Market
      • 13.6.10.1.1 China Teleneurology Market by Service
      • 13.6.10.1.2 China Teleneurology Market by End Use
      • 13.6.10.1.3 China Teleneurology Market by Application
    • 13.6.10.2 Japan Teleneurology Market
      • 13.6.10.2.1 Japan Teleneurology Market by Service
      • 13.6.10.2.2 Japan Teleneurology Market by End Use
      • 13.6.10.2.3 Japan Teleneurology Market by Application
    • 13.6.10.3 India Teleneurology Market
      • 13.6.10.3.1 India Teleneurology Market by Service
      • 13.6.10.3.2 India Teleneurology Market by End Use
      • 13.6.10.3.3 India Teleneurology Market by Application
    • 13.6.10.4 South Korea Teleneurology Market
      • 13.6.10.4.1 South Korea Teleneurology Market by Service
      • 13.6.10.4.2 South Korea Teleneurology Market by End Use
      • 13.6.10.4.3 South Korea Teleneurology Market by Application
    • 13.6.10.5 Singapore Teleneurology Market
      • 13.6.10.5.1 Singapore Teleneurology Market by Service
      • 13.6.10.5.2 Singapore Teleneurology Market by End Use
      • 13.6.10.5.3 Singapore Teleneurology Market by Application
    • 13.6.10.6 Malaysia Teleneurology Market
      • 13.6.10.6.1 Malaysia Teleneurology Market by Service
      • 13.6.10.6.2 Malaysia Teleneurology Market by End Use
      • 13.6.10.6.3 Malaysia Teleneurology Market by Application
    • 13.6.10.7 Rest of Asia Pacific Teleneurology Market
      • 13.6.10.7.1 Rest of Asia Pacific Teleneurology Market by Service
      • 13.6.10.7.2 Rest of Asia Pacific Teleneurology Market by End Use
      • 13.6.10.7.3 Rest of Asia Pacific Teleneurology Market by Application
• 13.7 LAMEA Teleneurology Market
• 13.8 Key Factors Impacting the Market
  • 13.8.1 Market Drivers
  • 13.8.2 Market Restraints
  • 13.8.3 Market Opportunities
  • 13.8.4 Market Challenges
  • 13.8.5 Market Trends - Teleneurology Market
  • 13.8.6 State of Competition Teleneurology Market
  • 13.8.7 LAMEA Teleneurology Market by Service
    • 13.8.7.1 LAMEA Tele-Consulting Market by Country
    • 13.8.7.2 LAMEA Tele-Monitoring Market by Country
    • 13.8.7.3 LAMEA Tele-Education Market by Country
  • 13.8.8 LAMEA Teleneurology Market by End Use
    • 13.8.8.1 LAMEA Providers Market by Country
    • 13.8.8.2 LAMEA Patients Market by Country
    • 13.8.8.3 LAMEA Payers Market by Country
  • 13.8.9 LAMEA Teleneurology Market by Application
    • 13.8.9.1 LAMEA Stroke Market by Country
    • 13.8.9.2 LAMEA Parkinson Market by Country
    • 13.8.9.3 LAMEA Epilipesy Market by Country
    • 13.8.9.4 LAMEA Headache Market by Country
    • 13.8.9.5 LAMEA Multiple sclerosis Market by Country
    • 13.8.9.6 LAMEA Dementia Market by Country
    • 13.8.9.7 LAMEA Other Application Market by Country
  • 13.8.10 LAMEA Teleneurology Market by Country
    • 13.8.10.1 Brazil Teleneurology Market
      • 13.8.10.1.1 Brazil Teleneurology Market by Service
      • 13.8.10.1.2 Brazil Teleneurology Market by End Use
      • 13.8.10.1.3 Brazil Teleneurology Market by Application
    • 13.8.10.2 Argentina Teleneurology Market
      • 13.8.10.2.1 Argentina Teleneurology Market by Service
      • 13.8.10.2.2 Argentina Teleneurology Market by End Use
      • 13.8.10.2.3 Argentina Teleneurology Market by Application
    • 13.8.10.3 UAE Teleneurology Market
      • 13.8.10.3.1 UAE Teleneurology Market by Service
      • 13.8.10.3.2 UAE Teleneurology Market by End Use
      • 13.8.10.3.3 UAE Teleneurology Market by Application
    • 13.8.10.4 Saudi Arabia Teleneurology Market
      • 13.8.10.4.1 Saudi Arabia Teleneurology Market by Service
      • 13.8.10.4.2 Saudi Arabia Teleneurology Market by End Use
      • 13.8.10.4.3 Saudi Arabia Teleneurology Market by Application
    • 13.8.10.5 South Africa Teleneurology Market
      • 13.8.10.5.1 South Africa Teleneurology Market by Service
      • 13.8.10.5.2 South Africa Teleneurology Market by End Use
      • 13.8.10.5.3 South Africa Teleneurology Market by Application
    • 13.8.10.6 Nigeria Teleneurology Market
      • 13.8.10.6.1 Nigeria Teleneurology Market by Service
      • 13.8.10.6.2 Nigeria Teleneurology Market by End Use
      • 13.8.10.6.3 Nigeria Teleneurology Market by Application
    • 13.8.10.7 Rest of LAMEA Teleneurology Market
      • 13.8.10.7.1 Rest of LAMEA Teleneurology Market by Service
      • 13.8.10.7.2 Rest of LAMEA Teleneurology Market by End Use
      • 13.8.10.7.3 Rest of LAMEA Teleneurology Market by Application

Chapter 14. Company Profiles

• 14.1 Teladoc Health, Inc.
  • 14.1.1 Company Overview
  • 14.1.2 Financial Analysis
  • 14.1.3 Segmental and Regional Analysis
  • 14.1.4 Research & Development Expenses
  • 14.1.5 SWOT Analysis
• 14.2 American Well Corporation (Amwell)
  • 14.2.1 Company Overview
  • 14.2.2 Financial Analysis
  • 14.2.3 Research & Development Expenses
  • 14.2.4 SWOT Analysis
• 14.3 MDLive, Inc.
  • 14.3.1 Company Overview
• 14.4 Blue Sky Telehealth (CarePoint, P.C.)
  • 14.4.1 Company Overview
• 14.5 Siemens Healthineers AG (Siemens AG)
  • 14.5.1 Company Overview
  • 14.5.2 Financial Analysis
  • 14.5.3 Segmental and Regional Analysis
  • 14.5.4 Research & Development Expense
  • 14.5.5 SWOT Analysis
• 14.6 Access TeleCare Holdings, Inc.
  • 14.6.1 Company Overview
• 14.7 Sevaro Health, Inc.
  • 14.7.1 Company Overview
  • 14.7.2 Recent strategies and developments:
    • 14.7.2.1 Partnerships, Collaborations, and Agreements:
    • 14.7.2.2 Product Launches and Product Expansions:
• 14.8 GlobalMed Holdings, LLC (GlobalMed)
  • 14.8.1 Company Overview
• 14.9 Lakewood Health System
  • 14.9.1 Company Overview
• 14.10. TeleSpecialists
  • 14.10.1 Company Overview

Chapter 15. Winning Imperatives of Teleneurology Market